AI K 운영 2026.10.21 (수) 22:57

GIST, 미학습 항암 후보물질 반응 예측 AI 개발…신약 선별 효율화 기대

베타뉴스 · 2026.10.19 10:06

원문 기사 보기 ↗

키워드: GIST · 미학습 · 항암 · 후보물질

댓글 0

아직 댓글이 없습니다.

이 기사가 속한 이슈

학습하지 않은 약물 반응도 예측···신약 후보물질 선별 AI 모델 개발

언론사 6곳이 기사 6건을 냈습니다. 보도 흐름 전체 보기

관련 기사

  1. Cardiologists Warn Against Hidden Sodium, Charred Meat and AlcoholSeoul Economic Daily
  2. South Korea's Self-Driving Freight Trucks Target Driverless Runs by 2028, Reshaping Domestic LogisticsBigGo Finance
  3. 김준하 GIST 교수 “피지컬 AI 시대, 중소기업 데이터 자산화가 경쟁력 좌우”브릿지경제
  4. Biologist David Sabatini wins $6 million in defamation lawsuitScience | AAAS
  5. 2 ‘Self-Critical’ Habits Of Highly Intelligent People, By A PsychologistForbes
  6. 'If I'm Fired Tomorrow It Will Be Because I Told You the Truth' — Xbox Business Strategist Deletes Social Media Account After Accusing the Game Industry of 'Pretending to Not Use AI'IGN
  7. Hyundai Motor, Kia to Test Level 4 Autonomous Trucks on 400km Logistics RouteBusinesskorea
  8. South Korea's Hyundai Motor, Kia to Deploy Level 4 Self-Driving Trucks on 400km Real-World Logistics RoutesBigGo Finance
  9. Hyundai Motor and Kia Demonstrate Level 4 Autonomous Trucks on Logistics Routes조선일보
  10. Hyundai Glovis seeks to expand vehicle logistics operations at Philadelphia portKorea JoongAng Daily